A groundbreaking oral drug, N-propargylglycine (N-PPG), has shown remarkable success in preventing fatal kidney damage in mice with Primary Hyperoxaluria Type 2 (PH2). This rare genetic disorder causes excessive oxalate buildup, leading to kidney failure. The drug effectively halts stone formation and protects kidneys, offering significant hope for a new treatment and potentially reducing the need for transplants.
Related Posts
Op Sindoor: MP min sparks row for ‘sister from terrorists’ community’ remark
Vijay Shah, a Madhya Pradesh minister, made controversial remarks about Colonel Sofia Qureshi. His comments drew criticism from opposition leaders. Congress president Mallikarjun Kharge condemned […]
Pawar ‘peeps into’ room as Ajit, Jayant hold closed-door meeting
Jayant Patil met NCP chief Ajit Pawar for a closed-door discussion at the VSI, which was attended by Sharad Pawar. Ajit Pawar downplayed speculations about […]
15 local cadres helped Pahalgam attackers: Probe
Indian authorities have identified fifteen local Kashmiri overground workers (OGWs) as suspects in facilitating the recent Pahalgam terror attack. Electronic surveillance revealed their potential involvement […]